Catalyst Wire Dossier Catalyst Wire Dossier

FOTIVDA

tivozanib · AVEO Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for FOTIVDA, covering 2021-03-10 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma

See pricing